Palvella Therapeutics, Inc. (PVLA)

100.66 -4.01 (-3.83%) USD  |  NASDAQ  |  Jan 02, 14:48
More

Palvella Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for PVLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Agenus, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Pelthos Therapeutics, Inc. Upgrade
Inhibrx Biosciences, Inc. Upgrade
CEL-SCI Corp. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade